BlackRock Health Sciences Term (BMEZ) vs Calamos Long/Short Equity & Dynamic Income (CPZ)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
BlackRock Health Sciences Term (BMEZ) has outperformed Calamos Long/Short Equity & Dynamic Income (CPZ) over the past year, gaining 11.9% versus a loss of 21.4%. Over five years, CPZ leads with a -39.5% price change compared with -39.5% for BMEZ. BlackRock Health Sciences Term is the larger company by market cap ($1.03 billion vs $246.2 million), about 4.2 times the size.
On valuation, BlackRock Health Sciences Term trades at a lower trailing P/E (4.9x vs 179.1x for Calamos Long/Short Equity & Dynamic Income).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BMEZ | CPZ |
|---|---|---|
| Share price | $16.53 | $12.54 |
| Market cap | $1.03B | $246.19M |
| 1-day change | +0.92% | +0.32% |
| YTD return | +9.83% | -14.23% |
| 1-year return | +11.92% | -21.43% |
| 5-year return | -39.54% | -39.54% |
| P/E ratio (TTM) | 4.88 | 179.14 |
| EPS (TTM) | $3.39 | $0.07 |
| Dividend yield | 7.99% | 13.40% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.25 | $16.21 |
| 52-week low | $13.70 | $12.39 |
| Distance from 52-week high | -4.17% | -22.65% |
| Average volume | 141.71K | 70.88K |
| Shares outstanding | 62.50M | 19.63M |
| Sector | Financial Services | Financial Services |
| Industry | Asset Management | Asset Management |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BlackRock Health Sciences Term is about 4.2 times larger than Calamos Long/Short Equity & Dynamic Income by market value ($1.03B vs $246.19M).
- BMEZ has outperformed CPZ by 33.3 percentage points over the past year.
- Calamos Long/Short Equity & Dynamic Income trades at a higher earnings multiple (179.1x vs 4.9x trailing P/E).
- Calamos Long/Short Equity & Dynamic Income offers a meaningfully higher dividend yield (13.40% vs 7.99%).
BMEZ vs CPZ FAQ
Which is bigger, BlackRock Health Sciences Term or Calamos Long/Short Equity & Dynamic Income?
BlackRock Health Sciences Term (BMEZ) is larger, with a market capitalization of $1.03B compared with $246.19M for Calamos Long/Short Equity & Dynamic Income (CPZ).
Which stock has performed better over the past year, BMEZ or CPZ?
BMEZ returned +11.92% over the past 12 months, compared with -21.43% for CPZ (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, BMEZ or CPZ?
BMEZ has the lower trailing P/E at 4.9, versus 179.1 for CPZ. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, BlackRock Health Sciences Term or Calamos Long/Short Equity & Dynamic Income?
Calamos Long/Short Equity & Dynamic Income has the higher yield at 13.40%, compared with 7.99% for BlackRock Health Sciences Term.
Are BlackRock Health Sciences Term and Calamos Long/Short Equity & Dynamic Income in the same industry?
Yes. Both are classified in the Asset Management industry within the Financial Services sector.